tiprankstipranks
Trending News
More News >
Fuso Pharmaceutical Industries,Ltd. (JP:4538)
:4538
Japanese Market
Advertisement

Fuso Pharmaceutical Industries,Ltd. (4538) Price & Analysis

Compare
0 Followers

4538 Stock Chart & Stats


Fuso Pharmaceutical Industries,Ltd. News

4538 FAQ

What was Fuso Pharmaceutical Industries,Ltd.’s price range in the past 12 months?
Fuso Pharmaceutical Industries,Ltd. lowest stock price was ¥2028.00 and its highest was ¥2858.00 in the past 12 months.
    What is Fuso Pharmaceutical Industries,Ltd.’s market cap?
    Fuso Pharmaceutical Industries,Ltd.’s market cap is ¥19.97B.
      When is Fuso Pharmaceutical Industries,Ltd.’s upcoming earnings report date?
      Fuso Pharmaceutical Industries,Ltd.’s upcoming earnings report date is Nov 06, 2025 which is in 88 days.
        How were Fuso Pharmaceutical Industries,Ltd.’s earnings last quarter?
        Fuso Pharmaceutical Industries,Ltd. released its earnings results on Aug 08, 2025. The company reported ¥54.099 earnings per share for the quarter, beating the consensus estimate of N/A by ¥54.099.
          Is Fuso Pharmaceutical Industries,Ltd. overvalued?
          According to Wall Street analysts Fuso Pharmaceutical Industries,Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Fuso Pharmaceutical Industries,Ltd. pay dividends?
            Fuso Pharmaceutical Industries,Ltd. pays a Semiannually dividend of ¥45 which represents an annual dividend yield of 3.6%. See more information on Fuso Pharmaceutical Industries,Ltd. dividends here
              What is Fuso Pharmaceutical Industries,Ltd.’s EPS estimate?
              Fuso Pharmaceutical Industries,Ltd.’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Fuso Pharmaceutical Industries,Ltd. have?
              Fuso Pharmaceutical Industries,Ltd. has 9,451,169 shares outstanding.
                What happened to Fuso Pharmaceutical Industries,Ltd.’s price movement after its last earnings report?
                Fuso Pharmaceutical Industries,Ltd. reported an EPS of ¥54.099 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.353%.
                  Which hedge fund is a major shareholder of Fuso Pharmaceutical Industries,Ltd.?
                  Currently, no hedge funds are holding shares in JP:4538

                  Company Description

                  Fuso Pharmaceutical Industries,Ltd.

                  Fuso Pharmaceutical Industries,Ltd. manufactures and sells pharmaceutical products in Japan. The company offers ethical drugs, such as injectables and artificial kidney dialysates; and medical machinery and equipment. It also rents real estate properties. The company was founded in 1937 and is headquartered in Osaka, Japan.

                  Fuso Pharmaceutical Industries,Ltd. (4538) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Wakamoto Pharmaceutical Co., Ltd.
                  Morishita Jintan Co., Ltd.
                  Nippon Chemiphar Co., Ltd.
                  Taiko Pharmaceutical Co., Ltd.
                  Daito Pharmaceutical Co., Ltd.

                  Ownership Overview

                  3.39%95.33%
                  Insiders
                  3.39%
                  Mutual Funds
                  ― Other Institutional Investors
                  95.33% Public Companies and
                  Individual Investors

                  Options Prices

                  Currently, No data available
                  ---
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis